These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 8773914)

  • 21. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
    Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
    Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.
    Terjung B; Worman HJ; Herzog V; Sauerbruch T; Spengler U
    Clin Exp Immunol; 2001 Oct; 126(1):37-46. PubMed ID: 11678897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
    Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
    Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geoepidemiology of autoimmune liver diseases.
    Invernizzi P
    J Autoimmun; 2010 May; 34(3):J300-6. PubMed ID: 20036105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.
    Targan SR; Landers C; Vidrich A; Czaja AJ
    Gastroenterology; 1995 Apr; 108(4):1159-66. PubMed ID: 7698584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease.
    Mulder AH; Horst G; Haagsma EB; Kleibeuker JH; Kallenberg CG
    Adv Exp Med Biol; 1993; 336():545-9. PubMed ID: 8296673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.
    Rigopoulou EI; Davies ET; Bogdanos DP; Liaskos C; Mytilinaiou M; Koukoulis GK; Dalekos GN; Vergani D
    Liver Int; 2007 Nov; 27(9):1226-31. PubMed ID: 17919234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and nature of the variant syndromes of autoimmune liver disease.
    Czaja AJ
    Hepatology; 1998 Aug; 28(2):360-5. PubMed ID: 9695997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F; Weber P; Klein R; Berg PA; Wiedmann KH
    Gut; 1992 May; 33(5):657-62. PubMed ID: 1612483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
    Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
    Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.
    Roozendaal C; de Jong MA; van den Berg AP; van Wijk RT; Limburg PC; Kallenberg CG
    J Hepatol; 2000 May; 32(5):734-41. PubMed ID: 10845659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review.
    Terziroli Beretta-Piccoli B; Invernizzi P; Gershwin ME; Mainetti C
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):394-412. PubMed ID: 28993983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.
    Peakman M; Lobo-Yeo A; Mieli-Vergani G; Davies ET; Mowat AP; Vergani D
    Clin Exp Immunol; 1987 Sep; 69(3):543-9. PubMed ID: 3665184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
    Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
    Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
    Sherlock S
    Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.
    Terjung B; Spengler U
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases.
    Griga T; Tromm A; Müller KM; May B
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):559-64. PubMed ID: 10833101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.